C11orf47 can engage distinct cellular pathways to bring about its functional activation. Forskolin, for example, directly targets adenylyl cyclase, which catalyzes the conversion of ATP to cAMP, an important secondary messenger. The elevated cAMP levels subsequently activate PKA (Protein Kinase A), which can phosphorylate C11orf47, thereby activating it. Similarly, Isoproterenol, a beta-adrenergic agonist, increases cAMP levels, again leading to the activation of PKA, which may phosphorylate and activate C11orf47. IBMX, by inhibiting phosphodiesterases, prevents the breakdown of cAMP, contributing to the activation of PKA and the phosphorylation of C11orf47. Dibutyryl-cAMP, a membrane-permeable analog of cAMP, can also activate PKA, potentially resulting in the phosphorylation and activation of C11orf47. Epinephrine interacts with adrenergic receptors and triggers a similar increase in cAMP and subsequent activation of PKA, which can activate C11orf47.
PMA, known for activating protein kinase C (PKC), has the capacity to phosphorylate and activate C11orf47 if PKC recognizes specific substrate sequences in the protein. Ionomycin and A23187, both calcium ionophores, elevate intracellular calcium levels, which can activate calcium-dependent protein kinases that may phosphorylate and activate C11orf47. Histamine operates through its G-protein-coupled receptor to activate phospholipase C (PLC), leading to a cascade that activates PKC, which could then activate C11orf47. Anisomycin, a protein synthesis inhibitor, can activate stress-activated protein kinases like JNK, which have the potential to directly phosphorylate and activate C11orf47. Calyculin A and Okadaic acid both act as inhibitors of protein phosphatases, leading to the enhanced phosphorylation of a range of proteins, which could include C11orf47, resulting in its activation. These chemical activators utilize various mechanisms within the cellular signaling environment to ensure the activation of C11orf47, acting through modifications such as phosphorylation that directly alter the function of the protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate C11orf47 if PKC has specificity for the substrate sequence found in C11orf47, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as an ionophore for calcium, increasing intracellular calcium levels, which can activate calcium-dependent protein kinases that might phosphorylate C11orf47, thereby activating it. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore similar to ionomycin, leading to increased intracellular calcium and the potential activation of calcium-dependent protein kinases that could phosphorylate and activate C11orf47. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, potentially activating PKA, which may then phosphorylate and activate C11orf47. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing cAMP breakdown, which can lead to PKA activation and subsequent phosphorylation and activation of C11orf47. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine, through its interaction with adrenergic receptors, can increase cAMP levels and thereby activate PKA, which in turn may phosphorylate and activate C11orf47. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Histamine, through its G-protein-coupled receptor, can activate PLC, leading to PKC activation, which could phosphorylate and activate C11orf47. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases like JNK, which might directly phosphorylate and activate C11orf47. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000C | 10 µg 100 µg 1 mg | $160.00 $750.00 $3000.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins, which could include C11orf47, resulting in its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that can activate PKA, potentially leading to the phosphorylation and activation of C11orf47. | ||||||